Midstream Health
AI-native financial-operations platform for hospital systems to identify and recover lost margin.
Website: https://www.midstream.health/
Cover Block
Open sources
| Field | Value |
|---|---|
| Name | Midstream Health |
| Tagline | AI-native financial-operations platform for hospital systems to identify and recover lost margin [Yahoo Finance, Oct 2026] |
| Headquarters | San Francisco, California [aVenture Company Research, retrieved 2026] |
| Founded | 2023 [Tracxn, Dec 2023] |
| Stage | Series A [Axios, Oct 2026] |
| Business model | SaaS |
| Industry | Healthtech |
| Technology | AI / Machine Learning |
| Geography | North America |
| Growth profile | Venture Scale |
| Founding team | Sumit Kadakia and Venkat Mocherla, co-founders [Markets Insider, retrieved 2026] [Equilar ExecAtlas, retrieved 2026] |
| Funding label | $10M+ |
| Total disclosed funding | Approximately $29.2 million [Yahoo Finance, Oct 2026] |
Links
Open sources
- Website: https://www.midstream.health/
What an Investor Needs First
PUBLIC Midstream Health is building financial-operations software for hospital systems, and it merits investor attention now because it has paired a young company profile with publicly named deployments at major U.S. health systems and a fresh $20 million Series A led by Valtruis [HITConsultant, Apr 2026] [HITConsultant, Mar 2026] [Axios, Oct 2026]. Founded in 2023 in San Francisco, the company is targeting a specific hospital pain point: margin already earned but lost through operational leakage, with an initial emphasis on supply chain, pharmacy, and managed care workflows [Midstream Health, retrieved 2026] [Tracxn, Dec 2023].
The product claim is straightforward, even if some of the language is company-authored: Midstream says it connects contract pricing, rebates, item master data, revenue, and cost inside one system, then uses domain-trained agents to identify and act on missed dollars rather than stopping at analytics alone [Midstream Health, retrieved 2026]. That action orientation is the central differentiator in the public record, alongside deployment references from Houston Methodist, CommonSpirit Health, and Mount Sinai, which suggest the company is selling into complex enterprise environments where point solutions often stall [CommonSpirit Health] [Yahoo Finance, Apr 2026] [Newswise].
The founding team brings a mix of operating and healthcare context that fits the wedge. Sumit Kadakia is identified as co-founder and CEO across multiple sources, while co-founder and president Venkat Mocherla previously worked at Andreessen Horowitz and has prior healthcare operating experience that includes Qventus and DaVita-related work, according to public profiles and interviews [Breaking Health Podcast, retrieved 2026] [RocketReach, retrieved 2026] [Crunchbase, retrieved 2026] [PitchBook, retrieved 2026].
On capitalization, the public record supports about $29.2 million in disclosed funding, including a $6.68 million early round in December 2023 and the October 2026 Series A, with investors including Valtruis, Andreessen Horowitz, Foundry, and CommonSpirit Ventures [Yahoo Finance, Oct 2026] [Tracxn, Dec 2023] [Axios, Oct 2026]. The model appears to be enterprise SaaS sold to health systems, though the available material does not yet establish pricing, retention, or revenue scale [Midstream Health, retrieved 2026].
Over the next 12 to 18 months, the key watchpoints are less about category demand and more about proof of repeatability: whether Midstream can turn named flagship deployments into broader customer density, whether it can show measurable financial recovery beyond supply chain use cases, and whether headcount and go-to-market capacity expand in step with its customer ambition [RocketReach, retrieved 2026] [Finsmes, Oct 2026]. The company has enough public traction to warrant attention, but the next phase of diligence should center on implementation depth, realized ROI, and how durable the product is once it moves from early lighthouse systems to a wider provider base [HITConsultant, Apr 2026] [HITConsultant, Mar 2026].
Partially corroborated -- This section combines independently reported funding and deployment references with company-authored product claims and single-source customer disclosures.
Taxonomy Snapshot
| Axis | Value |
|---|---|
| Stage | Series A |
| Business Model | SaaS |
| Industry / Vertical | Healthtech |
| Technology Type | AI / Machine Learning |
| Geography | North America |
| Growth Profile | Venture Scale |
| Founding Team | Co-Founders (2) |
| Funding | $29.2M disclosed |
Inside the Company
PUBLIC
Midstream Health is a young healthtech company making a fairly specific bet: hospital systems have already earned margin that gets lost in the handoff between contracts, pricing, rebates, payments, and internal operations. The company says it was founded in 2023, is headquartered in San Francisco, and built its platform to connect contract pricing, rebates, and item master data in one system for health systems [Midstream Health, retrieved 2026]. Crunchbase also lists Midstream Health as founded in 2023 and identifies co-founders Sumit Kadakia and Venkat Mocherla [Crunchbase, retrieved 2026].
The public record is still thin on formal corporate-history detail, but a few milestones are visible. Tracxn records a $6.68 million venture round in December 2023 [Tracxn, Dec 2023]. By October 2026, Axios reported that Midstream had raised a $20 million Series A led by Valtruis, and Yahoo Finance reported total disclosed funding of $29.2 million [Axios, Oct 2026] [Yahoo Finance, Oct 2026]. On the company website, Midstream presents itself as an autonomous financial operations platform for health systems, with an early emphasis on recovering missed dollars and improving margin in real time [Midstream Health, retrieved 2026].
Partially corroborated -- Core company identity is corroborated by the company website and Crunchbase, but milestone detail in this section relies partly on single-source funding records from Tracxn and Axios.
Under the Hood
MIXED Midstream Health is pitching a narrow but economically legible idea: hospital systems already have margin embedded in contracts, claims, rebates, and purchasing data, and the product is meant to surface and recover dollars that existing workflows miss [Midstream Health, retrieved 2026] [Breaking Health Podcast, retrieved 2026]. On its website, the company describes the platform as a financial-operations system that connects contract pricing, rebates, and item master data in one environment, then uses an "atomic-level" financial model to categorize and validate contract terms, claim lines, rebate conditions, and payments [Midstream Health, retrieved 2026]. That matters because the product claim is not generic analytics alone, but a data layer built around the operational details that drive hospital supply-chain and reimbursement leakage, at least as the company frames it publicly [Midstream Health, retrieved 2026] [Finsmes, Oct 2026].
Midstream also says the system deploys domain-trained agents across functions it names Recovery, Pricing, Optimizer, Negotiator, Reporter, and Pulse, with the stated goal of working transactions, invoices, claims, and rebate conditions continuously rather than at month-end [Midstream Health, retrieved 2026]. The company further represents that these agents automate contract reading and claims follow-up, while value engineers, forward-deployed engineers, and healthcare operators provide human judgment around the workflow [Midstream Health, retrieved 2026]. Public deployment announcements give some external contour to that positioning: Houston Methodist said it partnered with Midstream on an agentic AI financial platform aimed at identifying supply-chain leakage, and Mount Sinai said it was deploying the platform across a $1 billion supply chain with an initial focus on missing rebates [HITConsultant, Apr 2026] [HITConsultant, Mar 2026].
The technical picture is still incomplete in public materials. There is no verified public demo in the record here, and the available sources do not establish model providers, system architecture, implementation timelines, or measurable recovery rates by customer [Midstream Health, retrieved 2026] [Yahoo Finance, Apr 2026]. Even so, the public evidence is enough to say Midstream is positioning the product as an action-oriented financial operations layer for large health systems, with early proof points concentrated in supply chain and rebate recovery rather than a broad, fully documented enterprise finance suite [Midstream Health, retrieved 2026] [CommonSpirit Health, retrieved 2026] [HITConsultant, Mar 2026].
Claim stands unchecked -- Material product detail in this section is drawn primarily from the company website, with partial external corroboration from healthcare trade coverage of named deployments.
Market Research
PUBLIC
The market matters now because hospital operators are under sustained margin pressure, and Midstream Health is selling into a part of the budget where recovered dollars can matter faster than net-new growth initiatives, according to the company’s public customer references and product positioning [HITConsultant, Apr 2026] [HITConsultant, Mar 2026] [Midstream Health, retrieved 2026].
The public record does not provide a clean third-party TAM, SAM, or SOM for Midstream’s exact category, which sits between healthcare supply-chain software, revenue integrity, and AI-enabled financial operations. What is visible is the scale of the operating environments where the company says it is deployed: Houston Methodist, CommonSpirit Health, and Mount Sinai Health System were publicly named in 2026 as users or partners, and one public summary says those deployments collectively represent more than $80 billion in net patient revenue [HITConsultant, Apr 2026] [CommonSpirit Health] [HITConsultant, Mar 2026] [PERPLEXITY SONAR PRO BRIEF, retrieved 2026]. That is not a market size figure, but it does anchor the commercial target: large health systems with enough purchasing complexity, contract volume, and rebate exposure to justify a dedicated margin-recovery layer.
Demand signals are less about software line-item expansion than about finance teams searching for leakage that sits between existing systems. Midstream’s website describes the product as connecting contract pricing, rebates, item master data, revenue, and cost data in one system, then taking action to recover missed dollars and reduce spend [Midstream Health, retrieved 2026]. The named use cases in public deployments point in the same direction. Houston Methodist said it was deploying Midstream to identify supply chain leakage, while Mount Sinai said it was using the platform across a $1 billion supply chain with a focus on missing rebates [HITConsultant, Apr 2026] [HITConsultant, Mar 2026]. For investors, that suggests the budget may come from a blend of CFO, COO, and supply-chain mandates rather than a single narrow IT buying center.
The closest adjacent markets are established, even if Midstream’s exact wedge is newer. One substitute set is legacy revenue-cycle and contract-management tooling, which already serves hospital finance teams but typically focuses on claims, billing, or static contract administration rather than continuous transaction-level recovery, according to Midstream’s own positioning [Midstream Health, retrieved 2026]. Another adjacent market is healthcare supply-chain analytics, where the pain is not only procurement price variance but also rebate capture, item master integrity, and post-contract execution. A third is the broader market for enterprise healthcare AI, especially workflow automation products that promise measurable operational ROI. Midstream’s repeated framing of a "second financial brain" for health-system CFO and COO teams indicates it is trying to bridge those categories rather than fit neatly into one of them [Breaking Health Podcast, retrieved 2026] [PERPLEXITY SONAR PRO BRIEF, retrieved 2026].
Macro and regulatory context also help explain the timing. Health systems continue to face cost pressure, labor constraints, and scrutiny on operating performance, which makes recovered margin easier to defend internally than speculative transformation projects, according to the thrust of Midstream’s public customer announcements and founder interviews [Breaking Health Podcast, retrieved 2026] [Markets Insider, retrieved 2026]. At the same time, enterprise AI adoption in healthcare remains gated by trust, implementation friction, and the need to show measurable value quickly, themes discussed in public interviews featuring Midstream’s leadership [Becker’s Hospital Review, June 2026] [Becker Private Equity & Business Podcast, October 2025]. That combination favors vendors that can point to narrow, auditable use cases first, especially in non-clinical workflows where the compliance burden is meaningful but different from direct patient-care decisioning.
| Public sizing or scope signal | Figure | Interpretation |
|---|---|---|
| Disclosed total funding | $29.2M | Capital raised is enough to support enterprise go-to-market, but it is not itself evidence of market size [Yahoo Finance, Oct 2026] |
| Named deployment base net patient revenue | $80B+ | Indicates Midstream is targeting very large health systems rather than small or mid-market providers [PERPLEXITY SONAR PRO BRIEF, retrieved 2026] |
| Mount Sinai supply chain referenced in deployment announcement | $1B | Suggests one early wedge is large-scale supply chain margin capture inside major IDNs [HITConsultant, Mar 2026] |
The limited public numbers do not size the category, but they do show where the company is fishing. This looks less like a broad horizontal software market story and more like a high-value wedge into large-system financial operations, where a few enterprise accounts can support an early company if savings claims hold up in production.
Partially corroborated -- Relies on company announcements, trade press, and founder interviews; the section contains no independent third-party market sizing for Midstream’s exact category, and several market inferences are drawn from named deployments rather than external industry reports.
Competition and Substitutes
Market map
MIXED Midstream Health is positioned less against a single direct rival than against the patchwork of ERP, supply-chain, revenue-cycle, consulting, and internal analyst workflows that hospital systems already use to find and recover margin leakage [Midstream Health, retrieved 2026] [Breaking Health Podcast, retrieved 2026].
The public record here is thin on named head-to-head competitors, which matters in itself. Midstream describes its wedge as financial leakage recovery across supply chain, pharmacy, and managed care, with an operating model that links contract pricing, rebates, item master data, claim lines, and payments in one system rather than treating those as separate back-office queues [Midstream Health, retrieved 2026] [Markets Insider, retrieved 2026]. That puts the company at the intersection of several budget lines inside a health system, not squarely inside one established software category.
In practice, that means the incumbent set is likely fragmented. The installed alternatives for a large provider are often existing procurement systems, contract-management tools, revenue-cycle software, point consulting projects, and in-house finance teams using manual reconciliation across claims, invoices, and rebate workflows, although Midstream has not publicly named those vendors in direct competitive terms [Midstream Health, retrieved 2026] [Breaking Health Podcast, retrieved 2026]. Adjacent challengers include broader healthcare AI vendors with workflow credibility inside health systems, especially those with experience selling operational automation to provider executives, but the available source set does not establish specific displacement patterns.
The implication is that Midstream is trying to create a category boundary around "financial action" rather than entering a clean procurement lane. That can help early sales if the pain is real and budget owners span CFO, COO, and supply-chain leadership, but it can also lengthen evaluation because the buyer has to decide whether this is software, services, or a new control layer across existing systems [Breaking Health Podcast, retrieved 2026] [Midstream Health, retrieved 2026].
Edge and durability
MIXED The clearest edge visible today is not brand scale but credibility with large health systems and a product thesis built around messy financial source data that incumbents often leave fragmented [HITConsultant, Apr 2026] [HITConsultant, Mar 2026] [CommonSpirit Health, retrieved 2026].
Three public signals support that view. First, Midstream has publicly named deployments or implementations with Houston Methodist, CommonSpirit Health, and Mount Sinai Health System, all of which are material enterprise references for a company founded in 2023 [HITConsultant, Apr 2026] [CommonSpirit Health, retrieved 2026] [Newswise, retrieved 2026]. Second, the company frames the product around an atomic-level financial model and domain-trained agents that work contract terms, claims, invoices, and rebates continuously, which suggests the differentiation rests more on structured healthcare-finance data and workflow logic than on the base model layer alone [Midstream Health, retrieved 2026]. Third, the founding bench includes Venkat Mocherla, who is described as a former Andreessen Horowitz partner with prior healthcare operating roles, alongside CEO Sumit Kadakia, who has been the public voice for the company's unit-economics thesis in trade and podcast coverage [Andreessen Horowitz, retrieved 2026] [Crunchbase, retrieved 2026] [Breaking Health Podcast, retrieved 2026].
That edge looks real, but only partly durable from public evidence. Customer references at major systems can improve enterprise distribution and help a young company clear trust barriers faster than a typical healthtech startup [HITConsultant, Apr 2026] [HITConsultant, Mar 2026]. The more fragile part is the product layer: if the value depends mainly on applied AI orchestration over accessible hospital data, larger incumbents or adjacent workflow vendors could copy parts of the experience; if it depends on a proprietary, validated financial knowledge graph built from contracts, rebate conditions, and claim-level exceptions, the moat should strengthen with each deployment. Public materials support the second narrative, but they come mostly from the company, so durability remains more asserted than independently proven [Midstream Health, retrieved 2026].
Exposure points
MIXED The largest competitive exposure is that Midstream appears to sell into categories already touched by better-entrenched systems and services providers, while not obviously owning a mandatory system of record [Midstream Health, retrieved 2026] [Finsmes, Oct 2026].
That matters because hospitals do not rip out core administrative software lightly. A category incumbent with embedded workflows, approved integrations, and a long procurement history can defend accounts by adding leakage-detection features before a new platform becomes operationally central. Midstream's public positioning stresses action and continuous recovery, which is promising, but the sources do not yet show that it controls a proprietary channel, regulatory choke point, or exclusive data source that would prevent a larger vendor from bundling adjacent functionality [Midstream Health, retrieved 2026] [Markets Insider, retrieved 2026].
There is also a scope risk. The company's stated ambition spans supply chain, pharmacy, and managed care, which broadens the addressable problem set, but each of those domains has different data structures, stakeholders, and incumbent software stacks [PERPLEXITY SONAR PRO BRIEF, retrieved 2026] [Midstream Health, retrieved 2026]. Winning in one area does not automatically confer permission to expand across the rest. The near-term question is whether Midstream is best understood as a high-value wedge product for supply-chain and rebate recovery, or as a broader enterprise financial-operations platform that can consolidate several departmental tools.
Plausible 18-month scenario
MIXED The most plausible competitive scenario over the next 18 months is a bifurcation between platforms that can show audited, bottom-line recovery inside major systems and those that remain at the pilot or insight layer [Yahoo Finance, Oct 2026] [HITConsultant, Apr 2026] [HITConsultant, Mar 2026].
Winner if X: Midstream is one of the clearer potential winners if it can turn its named health-system deployments into repeatable proof that recovered dollars materially exceed implementation and change-management costs. The October 2026 Series A led by Valtruis gives it more room to deepen enterprise delivery and expand beyond a single use case, and public reference accounts such as Houston Methodist, CommonSpirit, and Mount Sinai are the kind of logos that can compound credibility if outcomes become more legible [Axios, Oct 2026] [Yahoo Finance, Oct 2026] [HITConsultant, Apr 2026] [CommonSpirit Health, retrieved 2026] [Newswise, retrieved 2026].
Loser if Y: point solutions that stop at surface-level anomaly detection are the most exposed if provider buyers insist on closed-loop execution rather than dashboards alone. Midstream's own product narrative is built around that distinction, and if the market validates it, vendors that cannot connect contract logic, claims, invoices, and rebate workflows into an action system could lose strategic ground, even if they remain useful departmental tools [Midstream Health, retrieved 2026] [Breaking Health Podcast, retrieved 2026]. The caution is that no named competitor is established in the source set, so this is a category-level scenario rather than a verified company-specific call.
Claim stands unchecked -- Core positioning and moat claims in this section rely heavily on company materials and podcast/interview coverage, with customer deployment evidence partially corroborated by healthcare trade publications and provider announcements.
Opportunity
PUBLIC
The prize here is unusually large if Midstream executes: hospital finance is a persistent margin problem measured in basis points but felt in billions of dollars across large systems, and Midstream has already surfaced enough public evidence of enterprise adoption to make a platform outcome conceivable rather than merely rhetorical [HITConsultant, Apr 2026] [HITConsultant, Mar 2026] [Yahoo Finance, Oct 2026].
The headline opportunity is to become the operating layer health systems use to detect and recover financial leakage across cost and revenue workflows, starting with supply chain and moving into adjacent domains where contracts, claims, rebates, and payments are fragmented across teams and systems [Midstream Health, retrieved 2026] [Breaking Health Podcast, retrieved 2026]. That is a bigger claim than selling point solutions into hospital back offices. It implies a system of record for financial action, not just analytics, and the public record gives that idea some footing: Houston Methodist, CommonSpirit Health, and Mount Sinai have each been named in connection with deployments or implementations, and Midstream has raised $29.2 million in disclosed funding, including a $20 million Series A led by Valtruis in October 2026 [HITConsultant, Apr 2026] [CommonSpirit Health] [HITConsultant, Mar 2026] [Yahoo Finance, Oct 2026] [Axios, Oct 2026].
The upside paths are still narrow, but they are visible enough to map.
| Scenario | What happens | Catalyst | Why it's plausible |
|---|---|---|---|
| Health-system standard for leakage recovery | Midstream becomes the preferred platform for CFO and COO teams at large provider organizations, first in supply chain and then in other margin-recovery workflows | Named enterprise deployments at Houston Methodist, CommonSpirit, and Mount Sinai create referenceability inside a concentrated buyer set [HITConsultant, Apr 2026] [CommonSpirit Health] [HITConsultant, Mar 2026] | The company is already positioned around enterprise financial operations rather than a single narrow workflow, and management describes the product as spanning supply chain, pharmacy, and managed care [Breaking Health Podcast, retrieved 2026] [Midstream Health, retrieved 2026] |
| Embedded operating layer for hospital margin management | Midstream moves from finding missed dollars to continuously adjudicating contracts, pricing, rebates, and payment exceptions across health systems | Product architecture that connects contract pricing, rebates, item master data, claim lines, and payments into one system [Midstream Health, retrieved 2026] | The product claims are broad, but they are internally coherent: if the platform is already normalizing these financial objects, adjacent automation becomes easier to add than a cold start in each new module [Midstream Health, retrieved 2026] |
| Coalition data advantage in provider finance | Midstream compounds learning across large provider customers and builds a differentiated data and workflow moat around healthcare financial operations | Publicly named customers include large systems such as Fairview Health Services, Keck Medicine of USC, CommonSpirit Health, Mount Sinai Health System, and Houston Methodist [Finsmes, Oct 2026] | Even with company-influenced sourcing, the customer list suggests exposure to varied purchasing, rebate, and contract structures. That matters in a category where the data model is part of the product, not just an input [Finsmes, Oct 2026] [Midstream Health, retrieved 2026] |
What compounding looks like is not a consumer-style network effect. It is a workflow and data flywheel. Midstream says it structures contract terms, claim lines, rebate conditions, and payments at atomic level, then applies domain-specific agents such as Recovery, Pricing, Optimizer, Negotiator, Reporter, and Pulse against those records [Midstream Health, retrieved 2026]. If that representation is accurate, each deployment should improve implementation speed, exception coverage, and playbook depth for the next one, especially inside large health systems that share similar categories of financial leakage.
There is also a distribution flywheel embedded in the early customer pattern. Reference accounts matter more in hospital software than they do in many horizontal SaaS categories, because buyers tend to scrutinize peer deployments, integration burden, and operational proof before expanding a new system across finance and supply chain teams. Publicly named work with Houston Methodist, CommonSpirit, and Mount Sinai gives Midstream precisely the sort of institutional credibility that can shorten that sales motion if outcomes are borne out after go-live [HITConsultant, Apr 2026] [CommonSpirit Health] [HITConsultant, Mar 2026].
The size of the win is harder to bound because no credible market-sizing study or direct public comparable was supplied in the source set. Even so, the outer edge is clear enough to state conditionally. If Midstream becomes a category leader in hospital financial operations software, with the product expanding from supply chain leakage into pharmacy, managed care, and broader margin management as management has described, the company could support a multibillion-dollar enterprise value over time (scenario, not a forecast), particularly because its named deployment base already touches health systems that the company and trade coverage associate with more than $80 billion in aggregate net patient revenue [Breaking Health Podcast, retrieved 2026] [Finsmes, Oct 2026]. That figure does not prove monetization, and it should not be read as revenue potential. It does show that the company is trying to solve a problem inside institutions large enough for a small improvement in realized margin to matter at enterprise scale [PERPLEXITY SONAR PRO BRIEF, retrieved 2026] [HITConsultant, Mar 2026].
Claim stands unchecked -- This section relies on a mix of trade-media reporting and company-sourced product claims, with no independently sourced market-sizing benchmark or public financial disclosures beyond funding.
Sources
Open sources
[Yahoo Finance, Oct 2026] Midstream Health Raises $20M Series A to Strengthen the Financial Sustainability of America’s Health Systems | https://finance.yahoo.com/healthcare/articles/midstream-health-raises-20m-series-130000580.html
[aVenture Company Research, retrieved 2026] Midstream Health - aVenture Company Research | https://aventure.vc/companies/midstream-health-oakland-ca-us
[Tracxn, Dec 2023] Midstream Health - 2026 Funding Rounds & List of Investors - Tracxn | https://tracxn.com/d/companies/midstreamhealth/__B-ORlzDm29XZaUblS-XX7SHc1Xr12Yju4B29XaK6X24/funding-and-investors
[Axios, Oct 2026] Exclusive: Revenue recovery startup Midstream Health raises $20M | https://www.axios.com/pro/health-tech-deals/2026/10/29/midstream-health-20m-revenue-recovery
[Markets Insider, retrieved 2026] Midstream Health Expands Leadership Amid Rapid Growth Across $80B+ Health System Coalition | https://markets.businessinsider.com/news/stocks/midstream-health-expands-leadership-amid-rapid-growth-across-80b-health-system-coalition-1036028860
[Equilar ExecAtlas, retrieved 2026] Venkat Mocherla | https://www.equilar.com/
[HITConsultant, Apr 2026] Houston Methodist deploys AI platform to identify supply chain leakage | https://hitconsultant.net/2026/04/10/houston-methodist-midstream-health-ai-supply-chain/
[HITConsultant, Mar 2026] Mount Sinai deploys agentic AI to recover missing supply chain rebates | https://hitconsultant.net/2026/03/13/mount-sinai-midstream-health-agentic-ai-supply-chain-rebates/
[Midstream Health, retrieved 2026] Midstream Health | https://www.midstream.health/
[CommonSpirit Health, retrieved 2026] CommonSpirit Health and Midstream Health partner to validate AI platform for supply chain operations | https://www.commonspirit.org/
[Breaking Health Podcast, retrieved 2026] Sumit Kadakia on Financial Intelligence For Hospitals | https://dhis.net/breaking-health-podcast/sumit-kadakia-on-financial-intelligence-for-hospitals
[RocketReach, retrieved 2026] Midstream Health | https://rocketreach.co/midstream-health-profile_b5f6c0b6f42e0c8d
[Crunchbase, retrieved 2026] Venkat Mocherla | https://www.crunchbase.com/person/venkat-mocherla
[PitchBook, retrieved 2026] Venkat Mocherla | https://pitchbook.com/
[Finsmes, Oct 2026] Midstream Health Raises $20M in Series A Funding | https://www.finsmes.com/2026/10/midstream-health-raises-20m-in-series-a-funding.html
[Newswise, retrieved 2026] Mount Sinai Health System is the first health system in New York City to use Midstream's financial action platform | https://www.newswise.com/
[Andreessen Horowitz, retrieved 2026] a16z Podcast: How To Pay For Healthcare Based on Health | https://a16z.com/podcast/a16z-podcast-how-to-pay-for-healthcare-based-on-health/
[Becker’s Hospital Review, June 2026] How AI Is Reshaping Healthcare’s Next Decade with Manav Sevak, Venkat Mocherla, & Malinka Walaliyadde | https://www.beckershospitalreview.com/podcasts/podcasts-beckers-hospital-review/how-ai-is-reshaping-healthcares-next-decade-with-manav-sevak-venkat-mocherla-malinka-walaliyadde.html
[Becker Private Equity & Business Podcast, October 2025] AI: Practical Growth & Use Cases 10-13-25 | https://www.beckershospitalreview.com/podcasts/podcasts-beckers-becker-private-equity-business-podcast/ai-practical-growth-use-cases-10-13-25.html
Articles about Midstream Health
- Midstream Health's AI Now Hunts for $80 Billion in Hospital Leaks — The startup, founded by an a16z veteran, is using agentic AI to recover missed rebates and contract dollars for CFOs.